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Objectives: Iatrogenic emboli may be released during carotid intervention, causing permanent neurologic complications
and catastrophic outcomes. This article reports the procedural details and clinical results of our series of neurosalvage
techniques to manage thromboembolic events during carotid procedures.
Methods: Between March 2003 and December 2007, 342 patients (283 men, 72.1  8.9 years old, 121 symptomatic)
underwent percutaneous stent deployment in 407 cervical internal carotid arteries in our institution. Visible distal
embolization with flow occlusion caused neurologic complications in 10 patients (2.5%), and a structured and stepwise
neurosalvage approach was attempted.
Results: Guidewire fragmentation and microcatheter injection of heparin and nitroglycerin were performed in all 10
patients as step 1. Intra-arterial thrombolysis was given in four patients and balloon angioplasty in five, as step 2.
Intracranial stenting was done in one patient as the last step. Successful angiographic recanalization (Thrombolysis in
Myocardial Infarction [TIMI] grade 2-3) occurred in 9 of 10 (90%). Residual neurologic sequel was observed in five,
including three patients with hemorrhage complications (1 received emergent craniotomy). There was no neurologic
mortality in this series.
Conclusions: Acute embolic complication during carotid artery stenting can be managed by catheter-based neurosalvage
with effective angiographic recanalization and marginal clinical success. ( J Vasc Surg 2010;52:308-13.)Carotid artery stenting (CAS) has been established as
an alternative to carotid endarterectomy in patients at high
surgical risk with internal carotid artery (ICA) stenosis.1
Ischemic complications may occur, however, mainly due to
procedure-related thromboembolism.2-5 Embolic protec-
tion devices (EPD) reduce the risk,5-7 but incomplete
device apposition8,9 or embolism before EPD deploy-
ment10 may still result in catastrophe.
When acute neurologic complications with visible em-
boli are noted, salvage maneuvers should be attempted to
re-establish adequate distal perfusion as soon as possible.
Intra-arterial thrombolysis may provide reperfusion,11 but
the associated risk of hemorrhage is devastating.12 Emboli
manipulation techniques, including retrieval devices, aspi-
ration catheters, and wire/balloon fragmentation, have
been applied in acute ischemic stroke but are seldom used
in complications associated with CAS.13 We present our
experience of stepwise neurosalvage techniques, combining
intra-arterial pharmacotherapy and mechanical emboli ma-
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308nipulation, in the management of macroembolic events
complicating CAS.
MATERIAL AND METHODS
The Institutional Review Board approved the retro-
spective review of patients’ medical and radiologic records.
Patients. Between March 2003 and December 2007,
CAS was done in 407 carotid arteries in 342 consecutive
patients (283 men, 72.1  8.9 years old). Procedures
included standard preprocedural dual antiplatelet therapy
with aspirin (100 mg/d) and clopidogrel (75 mg/d) for at
least 1 week, procedural heparin (70 U/ kg) with adequate
activated clotting time (200 to 250 seconds), distal EPD
(FilterWire EZ; Boston Scientific, Mountain View Calif, or
PercuSurge GuardWire; Medtronic, Minneapolis, Minn),
and self-expanding Carotid Wallstent (Boston Scientific,
Galway, Ireland). Among them, 10 patients (7 men, 73.7 
7.4 years old) sustained neurologic complications due to
visible distal embolization with flow occlusion, and catheter-
based techniques for neurosalvage were attempted.
Structured neurosalvage. When a neurologic deteri-
oration occurred unexpectedly during the procedure, intra-
cranial angiograms were compared carefully with the base-
line images. The structured neurosalvage approach that was
initiated when visible emboli were identified is summarized
as follows:
● Step 1. A 0.014-inch coronary angioplasty wire
(Runthrough NC Floppy; Terumo, Tokyo, Japan) was
advanced through a microcatheter (Excelsior; Boston
Scientific, Fremont, CA) across the emboli into the
distal vessel and rotated gently to fragment and dis-
lodge the embolus. If distal flow could not be restored,
tomat
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to the occlusion site as possible. The wire was with-
drawn and 2000 U of heparin and 100g of nitroglyc-
erin were given through the microcatheter.
● Step 2. If these maneuvers failed to restore adequate
flow, recombinant tissue plasminogen activator (rt-
PA) was administered through the microcatheter if
there was no contraindication. The protocol of rt-PA
was an initial slow bolus of 3 mg, followed by repeated
3-mg injections every 5 to 10 minutes until a total of
0.3 mg/kg was achieved or successful flow restoration
was documented by angiography. If thrombolysis
failed or was contraindicated, balloon angioplasty was
attempted as the next step. The microcatheter was
exchanged to a low-profile flexible coronary angio-
plasty balloon (1.5-  10-mm Ottimo EX; Kaneka,
Osaka, Japan), which was inflated to 2 to 4 atm to
fracture the embolus.
● Step 3. If the above steps did not restore perfusion,
intracranial stenting was attempted as the last resort.
Follow-up. Brain computed tomography (CT) with-
out contrast was performed immediately and 1 week after
the procedure. A complete neurologic examination, includ-
ing assessment of National Institutes of Health Stoke Scale
(NIHSS), was done by an independent neurologist 24
hours and 1 month later. Neurologic sequelae, intracranial
hemorrhage (ICH), and death were recorded.
Although the medical and radiologic records were re-
viewed retrospectively, the neurosalvage algorithm was de-
signed prospectively after 2003, and thereafter, all patients
with embolic complication were treated in strict accordance
with this stepwise approach. An angiogram was reviewed by
two independent technicians, blinded to the patients’ clin-
ical outcome at the time of interpretation, using the
Thrombolysis in Myocardial Infraction (TIMI) grading
system14:
● grade 0: no antegrade flow beyond the point of throm-
boembolic occlusion;
● grade 1: contrast material passes beyond the area of
Table I. Baseline clinical and procedural data





1 72 M Stroke Right
2 67 M Stroke Left
3 68 M No Left
4 70 M No Left
5 73 M No Right
6 84 F No Left
7 86 F Stroke Left
8 77 F TIA Left
9 79 M No Left
10 61 M No Left
A1, Segment of anterior cerebral artery; CAS, carotid artery stenting; EPD, e
segments of middle cerebral artery; NASCET, North American Symp
vertebrobasilar.obstruction but fails to opacify the entire coronary beddistal to the obstruction for the duration of the cinean-
giographic filming sequence;
● grade 2: contrast material passes across the obstruction
and opacifies the coronary artery distal to the obstruc-
tion, but the rate of entry and clearance is perceptibly
slower than nonoccluded area vessels; and
● grade 3: antegrade flow into the arterial bed distal to
the occlusion occurring promptly as clearance with
flow comparable to that of nonoccluded area vessels).
Successful angiographic recanalization was predefined
as TIMI 2/3 flow at the end of the procedure.
RESULTS
Baseline clinical data of the 10 patients who underwent
neurosalvage are listed in Table I. Patients were an average
age of 73.7  7.4 years (range, 61-86 years), and seven
were men (70%). Four patients were symptomatic accord-
ing to the North American Symptomatic Carotid Endarter-
ectomy Trial (NASCET) criteria.15 Embolic events oc-
curred before EPD deployment in eight patients (80%).
The embolized locations were the M1 segment of the
middle cerebral artery in 2 patients, the M2/M3 segments
in 6, the A1 segment of the anterior cerebral artery in 1, and
the vertebrobasilar junction in 1. Five embolic events oc-
curred in territories nonipsilateral to the treatment artery.
The steps applied for neurosalvage and their results are
summarized in Tables II and III. Step 1 was performed to
all 10 patients, resulting in complete reperfusion (TIMI 3
flow) in patients 6 and 10. Step 2 was performed in the
residual eight patients. Rt-PA thrombolysis was done in
patients 3, 4, 5, and 9 underwent rt-PA thrombolysis,
which achieved TIMI 3 flow in patient 9 and TIMI 2 in
patients 3 and 4. Patient 5, with failed thrombolysis, re-
ceived further balloon angioplasty, and TIMI 3 flow was
restored. Patients 1, 2, 7, and 8, with contraindications for
thrombolysis (one had a platelet count100 103L and
three had history of stroke within the previous 6 weeks)
were treated with balloon angioplasty as step 2. TIMI 2
flow was achieved in patients 7 and 8. Patient 2, one of the
Cause of embolic event
CAS with EPD
was done or not
Embolized
site
iagnostic angiography No M1, left
C engagement No M1/M2, left
ostdilatation Yes A1, left
iagnostic angiography No M3, right
iagnostic angiography No M3, left
iagnostic angiography No VB junction
iagnostic angiography No M2, left
iagnostic angiography No M3, left
ostdilatation Yes M2, left
iagnostic angiography No M1, right
c protection devices; F, female; GC, guiding catheter; M, male; M1/M2/M3,
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TIMI 2 flow.
The acute neurologic deterioration recovered com-
pletely in patients 5, 6, 8, 9, and 10 after salvage. ICH or
subarachnoid hemorrhage was detected immediately by
postprocedural CT in patients 1, 4, and 7, and life-saving
craniotomy was done in patient 4. A new infarction was
found by CT in patients 1, 2, 3, 4, 7, and 8, but only a
residual neurologic deficit was observed in five patients at 1
month. No neurologic death occurred in this series up to
12 months.
Example case of neurosalvage with intracranial
stenting. Elective carotid artery stenting was attempted in
patient 2, a 67-year-old man with symptomatic left ICA
stenosis. Ipsilateral ischemic stroke occurred 1 month be-
fore the procedure, with good functional recovery. Carotid
endarterectomy was not suggested due to high surgical risk
(coronary multivessel disease, congestive heart failure, and
obesity with a short neck). The patient’s aortic arch was
very tortuous and atheromatous. Consciousness change
and right limb weakness were noted during the difficult
guiding catheter engagement. An angiogram showed acute
Table II. Steps of neurosalvage procedure and angiograph
Pt.
Presalvage








1 0 Yes 0 CI . .
2 1 Yes 1 CI . .
3 0 Yes 1 15 2
4 0 Yes 0 9 2
5 0 Yes 0 21 1
6 1 Yes 3 0 . .
7 0 Yes 0 CI . .
8 0 Yes 1 CI . .
9 0 Yes 0 15 3
10 0 Yes 3 0 . .
CI, Contraindicated; IA, intra-arterial; rt-PA, recombinant tissue plasmino
aWire fragmentation with intra-arterial heparin and nitroglycerine.








1 Subarachnoid Yes 3
2 No Yes 2




5 No No 0
6 No No 0
7 Left intracranial Yes 5
8 No Yes 0
9 No No 0
0 No No 0
CT, Computed tomography; NIHSS, National Institutes of Health Stroke
ventilated.
aHemorrhagic complications were assessed immediately by postproceduralleft M1 occlusion, very likely embolic in origin (Fig, A).Neurosalvage procedures, including steps 1 and 2
(Fig, B), were performed, but recanalization was only par-
tial (Fig, C). Balloon angioplasty instead of thrombolysis
was chosen as step 2 in this patient, who had a history of
infarction only 1 month earlier. A Driver (Medtronic)
balloon-expandable 2.25-  18-mm stent (Fig, D) was
deployed as step 3, restoring TIMI 2 flow to the distal
MCA territory (Fig, E). A brain CT 24 hours later showed
a new focal low-density area with mass effect in the left
insular region.
The patient was discharged 5 days after the procedure
and was prescribed dual antiplatelet therapy. NIHSS was 3
with residual motor aphasia and dysarthria at the 1-month
follow-up. He was admitted again 6 months later to com-
plete the intended left ICA stenting. The angiogram re-
vealed a patent intracranial stent with insignificant neointi-
mal proliferation (Fig, F).
DISCUSSION
Cerebral embolism may occur during any endovascular
maneuver,16-19 but it is the most important complication in











Yes 1 No 1
Yes 1 Yes 2
No . . . No 2
No . . . No 2
Yes 3 No 3
No . . . No 3
Yes 2 No 2
Yes 2 No 2
No . . . No 3
No . . . No 3
tivator; TIMI, Thrombolysis in Myocardial Infarction.
valuation
Neurologic deficit at 1 monstprocedure 1 mon
9 8 Right hemiparesis, dysarthria
5 3 Motor aphasia, dysarthria
10 8 Right hemiparesis, slurred speech
NA 12 Emergent craniotomy; left hemiplegia
3 0 No deficit
0 0 No deficit
NA NA Ventilator dependent
2 0 No deficit
3 0 No deficit
0 0 No deficit












Scaletor to be familiar with the intracranial circulation and
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Volume 52, Number 2 Lin et al 311Fig. Intracranial stenting with balloon-expandable stent for neurosalvage is shown in patient 2. A, Cerebral angiogram shows
occlusion of the left middle cerebral artery, M1/M2 segments (arrow). B, Guidewire fragmentation and balloon angioplasty.
C, Partial recanalization of the M1/M2 after balloon angioplasty. D, Balloon-expandable stent deployment. E, Successful
recanalizationafter stenting.F,Follow-upangiogram6months later showspatent stentwithmildneointimalproliferation(arrow).
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neurosalvage, should this complication occur. To the best
of our knowledge, this is the largest neurosalvage experi-
ence to be published. We report our systematic approach
that uses a tiered complexity of techniques to manage
visible thromboemboli that occur during CAS. Despite
complete flow interruption at the time of detection, suc-
cessful angiographic reperfusion with TIMI 2/3 flow could
be achieved in 90% of the patients. However, 5 of the 10
patients had residual neurologic deficits after salvage, al-
though there was no neurologic mortality in this series.
Urokinase or rt-PA has been shown to be a safe and
effective therapy for acute ischemic stroke.20,21 However,
the effect of lytic therapy in managing acute embolic com-
plications of CAS is only marginal.11 Hähnel et al22 re-
ported the results of intra-arterial thrombolysis with rela-
tively high doses of rt-PA for intracerebral thromboemboli
that occurred during neuroendovascular procedures. Re-
canalization (TIMI 2 or 3 flow) rate was 44% (4 of 9), and
clinical outcomes were disappointing. In the study by Ar-
nold et al,23 12 patients with acute stroke due to compli-
cations from arterial catheter interventions were treated
with intra-arterial urokinase infusion. Although the recan-
alization rate (TIMI 2/3) was 92% (11 of 12), mechanical
thrombus disruption was partly responsible for the effect.
Otherwise, none of the patients had previous neurologic
deficits in this series.
A possible explanation for the discrepancy in the effects
of lytic therapy for acute stroke and iatrogenic embolism is
the difference in the embolic material. Embolic particles
liberated during CAS have a high cholesterol content and
are relatively large in size.24 These bulky plaque-like emboli
could not be effectively dissolved by thrombolytic agents.25
In addition, large clot is more resistant to lytic enzymes due
to a small surface-to-volume ratio.26 Mechanical thrombus
fragmentation, achieved by guidewire or balloon manipu-
lation, not only increases the reactive emboli surface acces-
sible to the lytic agents but also establishes temporary flow
through and beyond the emboli. The latter mechanism
allows for further increase in the contact surface between
the lytic agents and the embolus.
In our series, the combination of physical thrombus
fragmentation and intra-arterial pharmacologic therapy as
steps 1 and 2 was able to achieve successful recanalization
(TIMI 2 or 3 flow) in 8 of 10 patients (80%). The recana-
lization rate is significantly higher than those of lytic ther-
apy alone in embolic complications during CAS11 or other
neuroendovascular procedures.22,27
Glycoprotein (Gp) IIb/IIa inhibitors could facilitate
the rate and extent of fibrinolysis by improving the rt-PA
binding velocity, especially in platelet-rich thrombi.28 The
benefit of Gp IIb/IIIa has been described in acute and
subacute stent thrombosis after coronary,29 renal,30 and
carotid stenting.31 Studies have also shown the therapeutic
potential of Gp IIb/IIIa inhibitors in acute stroke.32,33
Kittusamy et al34 described two cases of acute embolization
during CAS treated successfully with intra-arterial abcix-
imab.34 Although Gp IIb/IIIa inhibitor was not an integerof our current neurosalvage regimen, its potential and risk
should be evaluated in future studies.
Mechanical removal of the emboli is another neurosal-
vage option. The aspiration lumen of any catheters that can
traverse the tortuous intracranial vessels will not be large
enough to generate effective suction; hence, the success
rate in retrieving thrombotic material in vivo was only
39.4%.35 Mechanical emboli retrieval devices may be an
effective option. The clinical efficacy of the Merci retriever
in acute ischemic stroke was reported recently,36 and its
therapeutic potential in embolic complications during CAS
may warrant further study. However, its limited availability
in countries outside Europe is a major issue.
Use of intracranial self-expanding stents in elective
intracranial atheromatous stenosis or acute ischemic stroke
interventions had been shown,37,38 but its application in
embolic complication of endovascular procedure has not
been reported. Qureshi et al39 described two acute ischemic
stroke patients in whom reocclusion of the recanalized arteries
occurred after local thrombolysis. Balloon-expandable stents
were used for rescue (1 in the distal ICA, 1 in M1) but were
thought to be too rigid for the tortuous intracranial vessels
and were associated with high periprocedural complication
rates.40 With the advance in alloy technology and stent
geometry, however, current balloon-expandable stents are
more flexible and deliverable.
CONCLUSIONS
Our experience demonstrates that a structured catheter-
based approach, combining stepwise intra-arterial pharma-
cologic therapy and mechanical emboli manipulation, is
feasible in salvaging acute embolic complications during
CAS. It was associated with a high rate of angiographic
recanalization, but 50% of patients still had persistent neu-
rologic deficit despite aggressive attempt at neurosalvage.
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